GB9820417D0 - Antiviral combinations - Google Patents

Antiviral combinations

Info

Publication number
GB9820417D0
GB9820417D0 GBGB9820417.5A GB9820417A GB9820417D0 GB 9820417 D0 GB9820417 D0 GB 9820417D0 GB 9820417 A GB9820417 A GB 9820417A GB 9820417 D0 GB9820417 D0 GB 9820417D0
Authority
GB
United Kingdom
Prior art keywords
antiviral combinations
antiviral
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9820417.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9820417.5A priority Critical patent/GB9820417D0/en
Publication of GB9820417D0 publication Critical patent/GB9820417D0/en
Priority to CN99811006A priority patent/CN1317971A/en
Priority to JP2000573740A priority patent/JP2002526449A/en
Priority to KR1020017003499A priority patent/KR20010075202A/en
Priority to AU60850/99A priority patent/AU6085099A/en
Priority to EP99947375A priority patent/EP1113803A1/en
Priority to PCT/EP1999/006885 priority patent/WO2000016779A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB9820417.5A 1998-09-18 1998-09-18 Antiviral combinations Ceased GB9820417D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9820417.5A GB9820417D0 (en) 1998-09-18 1998-09-18 Antiviral combinations
CN99811006A CN1317971A (en) 1998-09-18 1999-09-17 Antiviral combination comprising lamivudine and abacavir
JP2000573740A JP2002526449A (en) 1998-09-18 1999-09-17 Antiviral combination preparation comprising lamivudine and abacavir
KR1020017003499A KR20010075202A (en) 1998-09-18 1999-09-17 Antiviral Combinations Comprising Lamivudine and Abacavir
AU60850/99A AU6085099A (en) 1998-09-18 1999-09-17 Antiviral combinations comprising lamivudine and abacavir
EP99947375A EP1113803A1 (en) 1998-09-18 1999-09-17 Antiviral combinations comprising lamivudine and abacavir
PCT/EP1999/006885 WO2000016779A1 (en) 1998-09-18 1999-09-17 Antiviral combinations comprising lamivudine and abacavir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9820417.5A GB9820417D0 (en) 1998-09-18 1998-09-18 Antiviral combinations

Publications (1)

Publication Number Publication Date
GB9820417D0 true GB9820417D0 (en) 1998-11-11

Family

ID=10839131

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9820417.5A Ceased GB9820417D0 (en) 1998-09-18 1998-09-18 Antiviral combinations

Country Status (7)

Country Link
EP (1) EP1113803A1 (en)
JP (1) JP2002526449A (en)
KR (1) KR20010075202A (en)
CN (1) CN1317971A (en)
AU (1) AU6085099A (en)
GB (1) GB9820417D0 (en)
WO (1) WO2000016779A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230698B1 (en) 2000-02-29 2017-09-28 Bristol-Myers Squibb Holdings Ireland Low dose entecavir formulation and use thereof
AR040242A1 (en) * 2002-06-04 2005-03-23 Glaxo Group Ltd PHARMACEUTICAL COMPOSITIONS
PL373758A1 (en) * 2002-06-27 2005-09-05 Medivir Ab Synergistic interaction of abacavir and alovudine
WO2012062835A1 (en) * 2010-11-12 2012-05-18 Glaxo Wellcome Manufacturing Pte Ltd Novel pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
CO4970782A1 (en) * 1997-11-13 2000-11-07 Merck & Co Inc COMBINED THERAPY FOR THE TREATMENT OF AIDS
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
WO2000016779A1 (en) 2000-03-30
AU6085099A (en) 2000-04-10
JP2002526449A (en) 2002-08-20
EP1113803A1 (en) 2001-07-11
CN1317971A (en) 2001-10-17
KR20010075202A (en) 2001-08-09

Similar Documents

Publication Publication Date Title
GB9815567D0 (en) Antiviral compound
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
HUP9903290A3 (en) Sulfanilsilanes
GB9807354D0 (en) Antiviral compound
DE59903023D1 (en) Perorale wirkstoff-suspension
GB9804469D0 (en) Antiviral composition
DE59914151D1 (en) Arylalkanoylpyridazine
DE60042897D1 (en) Photovervielfacherröhre
ZA984083B (en) Antiviral combinations.
IL141844A0 (en) Antiviral combinations
DE59904407D1 (en) Chromanderivate
PL341819A1 (en) Antiviral agents
DE69821502D1 (en) Boroskop
GB9807355D0 (en) Antiviral compound
DE59900495D1 (en) Multimetalloxidmassen
HUP0105165A3 (en) Lichting arrangement
GB9808496D0 (en) Resistance-monitoring arrangement
DE59900471D1 (en) Inchbremseinrichtung
GB9820417D0 (en) Antiviral combinations
ZA975565B (en) Antiviral combinations
HUP9903242A3 (en) Special adhesive-bond
GB9821000D0 (en) Antiviral combinations
DE59905941D1 (en) Methoximinophenylessigsäureamide
GB9820416D0 (en) Antiviral combinations
DE59911094D1 (en) Tryptase-inhibitoren

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)